Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by BROOKS, P. M.
Right arrow Articles by HILLS, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BROOKS, P. M.
Right arrow Articles by HILLS, L. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1982 British Society for Rheumatology

research-article

EVALUATION OF A SINGLE DAILY DOSE NAPROXEN IN OSTEOARTHRITIS

P. M. BROOKS1,, L. G. CLELAND2, A. L. HASKI3, D. B. HEMPTON4, J. N. MULLER5 and L. J. HILLS6

1Rheumatology Services, Flinders Medical Centre Bedford Park, 5042
2Queen Elixabeth Hospital Woodville, 5011
3 97 Edgecliffe Road,Bondi Junction, 2022
4 20 Everton Road, Strathfield
5 425 Sydney Road, Balgowlah, 2093
6 N.S.W. Institute of Technology, Broadway, 2006 Australia

Correspondence to: Requests for reprints to Dr. P.M. Broods.

A six-week double-blind randomized cross-over trial comparing the safety and efficacy of 250 mg naproxen administered twice daily and 500 mg naproxen administered as a single dose at night in osteoarthritic patients stabilized on naproxen 250 mg twice daily is reported.

There was no significant difference between the two regimens. This study provides evidence that naproxen can be given to patients with osteoarthritis on a single-daily-dose regimen without any loss of anti-inflammatory/analgesic activity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.